Prostate Cancer Risk Assessment Using Genetic Markers in General Practice
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening
Number of low risk patients who get a PSA test
The primary objective of this study is to evaluate the impact on use of PSA tests of introducing genetic PCa risk assessment in general practice.
1 year, 2 years
Pia Kirkegaard, PhD
The Research Unit for General Practice, Aarhus University, Denmark
Denmark: Danish Dataprotection Agency